Division of Molecular and Cellular Biology, Department of Anatomy, Faculty of Medicine, University of Miyazaki, Kihara 5200, Kiyotake, Miyazaki, 889-1692, Japan.
J Bone Miner Metab. 2010 Mar;28(2):131-8. doi: 10.1007/s00774-009-0117-z. Epub 2009 Sep 17.
Endoplasmic reticulum (ER) stress response is important for protein maturation in the ER. Some murine models for bone diseases have provided significant insight into the possibility that pathogenesis of osteoporosis is related to ER stress response of osteoblasts. We examined a possible correlation between osteoporosis and ER stress response. Bone specimens from 8 osteoporosis patients and 8 disease-controls were used for immunohistochemical analysis. We found that ER molecular chaperones, such as BiP (immunoglobulin heavy-chain binding protein) and PDI (protein-disulfide isomerase) are down-regulated in osteoblasts from osteoporosis patients. Based on this result, we hypothesized that up-regulation of ER molecular chaperones in osteoblasts could restore decreased bone formation in osteoporosis. Therefore, we investigated whether treatment of murine model for osteoporosis with BIX (BiP inducer X), selective inducer BiP, could prevent bone loss. We found that oral administration of BIX effectively improves decline in bone formation through the activation of folding and secretion of bone matrix proteins. Considering these results together, BIX may be a potential therapeutic agent for the prevention of bone loss in osteoporosis patients.
内质网(ER)应激反应对于 ER 中蛋白质的成熟很重要。一些用于骨骼疾病的鼠类模型为骨质疏松症的发病机制与成骨细胞的 ER 应激反应有关的可能性提供了重要的见解。我们研究了骨质疏松症与 ER 应激反应之间的可能相关性。使用 8 例骨质疏松症患者和 8 例疾病对照的骨标本进行免疫组织化学分析。我们发现 ER 分子伴侣,如 BiP(免疫球蛋白重链结合蛋白)和 PDI(蛋白质二硫键异构酶)在骨质疏松症患者的成骨细胞中下调。基于这一结果,我们假设成骨细胞中 ER 分子伴侣的上调可以恢复骨质疏松症中减少的骨形成。因此,我们研究了用 BIX(BiP 诱导剂 X),一种选择性诱导 BiP 的药物治疗骨质疏松症的鼠类模型是否可以预防骨丢失。我们发现,BIX 的口服给药通过骨基质蛋白折叠和分泌的激活,有效地改善了骨形成的下降。综合这些结果,BIX 可能是预防骨质疏松症患者骨丢失的一种潜在治疗剂。